Previous 10 | Next 10 |
While the aesthetics market is growing at a substantial pace, not every company in this field has been doing well. Medical aesthetics product maker Sientra (NASDAQ: SIEN) has been on a downward trend over the past year, giving back around half of its market value during that time frame. Howe...
Sientra, Inc. (SIEN) Q3 2019 Earnings Conference Call November 7, 2019 5:00 PM ET Company Participants Neil Bhalodkar – Senior Director-Investor Relations Jeff Nugent – Chairman and Chief Executive Officer Paul Little – Chief Financial Officer, Senior Vice Pr...
Image source: The Motley Fool. Sientra (NASDAQ: SIEN) Q3 2019 Earnings Call Nov 07, 2019 , 5:00 p.m. ET Operator Continue reading
Gainers: Leaf Group (NYSE: LEAF ) +40% . More news on: Leaf Group Ltd., Clovis Oncology, Inc., RAPT Therapeutics, Inc., Stocks on the move, Read more ...
Sientra ( SIEN +25.7% ) is up on triple normal volume after its Q3 report released after the close yesterday. Highlights: More news on: Sientra, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Dermira (NASDAQ: DERM ) +29% on apparent reaction to AnaptysBio's etokimab flop in a mid-stage atopic dermatitis study. More news on: Dermira, Inc., ObsEva SA, Sientra, Inc., Stocks on the move, Read more ...
Sientra (NASDAQ: SIEN ): Q3 GAAP EPS of -$0.45 beats by $0.02 . More news on: Sientra, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Highlights: Record total net sales of $22.4 million in 3Q19, growth of 33% year over year Breast Products net sales of $12.6 million in 3Q19, growth of 47% year over year Record miraDry net sales of $9.8 million in 3Q19, growth of 18% year over year Increases 2019 total ...
Vertical integration critical next step in advancing Sientra’s strategic objectives Insourcing of breast implant supply chain provides numerous operational and financial advantages SANTA BARBARA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medic...
Apellis Pharma (NASDAQ: APLS ) initiated with Neutral rating and $33 (8% upside) price target at Credit Suisse. More news on: Apellis Pharmaceuticals, Inc., Aphria Inc., argenx SE, Healthcare stocks news, Stocks on the move, , Consumer stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Tiger Aesthetics Medical, LLC is the successful bidder for certain assets used in Sientra's breast reconstruction and augmentation business N...
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) fell 4.6% to $0.7055 on volume of 174,330,167 shares PROSHARES TRUST (SQQQ) rose 2.3% to $11.92 on volume of 147,409,535 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.0% to $4.61 on volume ...
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results. Fluor posted adjusted earnings of 68...